Qualitas Health and Valicor Renewables Announce Strategic Partnership to Commercialize Algae-Based Omega-3 SupplementsPosted On: February 24, 2013
Qualitas Health and Valicor Renewables announced today a strategic partnership that will accelerate the launch of high-EPA Omega-3 oil from algae. The companies have joined forces to combine their expertise and experience in biology, advanced chemistry and technology commercialization to make a significant impact on the global Omega-3 market with next-generation algae based products.
Solarvest has made significant progress in its plans to use its patented algal technology to develop commercial products focused on health care. The Company recently completed negotiations to acquire a 30,000 sq. ft. facility in Summerville Prince Edward Island which will be repurposed to house the Company’s planned algal production. Solarvest has acquired the facility on a lease to own basis for $436,000 with an 8-year term, the previous owner had invested in excess of $2.2 million in developing the facility.
A new study suggests that people with early Alzheimer’s disease can be benefited by a drink containing some special nutrients.
Online edition of Journal of Alzheimer’s Disease contained this report, published on 10 July.
Alzheimer patients lose memory as the disease progresses due to the deteriorating connectivity among brain cells. Souvenaid, drink with special nutrients, can improvise this connection, said Dr. Richard Wurtman, Massachusetts Institute of Technology scientist.
Sovenaid contains three ingredients, choline, uridine and omega-3 fatty acids. Choline is B vitamin and can be found in meats, nuts and eggs. Fishes, eggs, flaxseed and meat of grass fed animals have omega-3 fatty acids. Uridine can also be gained from some food as part of RNA and it helps in making protein in the body.
These nutrients with some other essential proteins are required to make cell membranes that form synapses(connections between brain cells).
But according to William Thies, vice president for medical and scientific affairs at the Alzheimer’s Association, Souvenaid requires more research before it could go public and even then consumers need to be cautious.
We’ve all heard that eating fish is good for our brains and memory. But what is it about DHA, an omega-3 fatty acid found in fish, that makes our memory sharper?
Medical researchers at the University of Alberta have discovered a possible explanation. Their findings have been published in the peer-reviewed journal Applied Physiology, Nutrition, and Metabolism.
Principal investigator Yves Sauvé and his team discovered that lab models fed a high-DHA diet had 30 per cent higher levels of DHA in the memory section of the brain, known as the hippocampus, than lab models on a regular, healthy diet.
“We wanted to find out how fish intake improves memory,” says Sauvé, a researcher in the Faculty of Medicine & Dentistry who works in the departments of physiology and ophthalmology, and in the Centre for Neuroscience.
“What we discovered is that memory cells in the hippocampus could communicate better with each other and better relay messages when DHA levels in that region of the brain were higher. This could explain why memory improves on a high-DHA diet.”
Sauvé noted a key finding was that when a diet is supplemented with DHA, additional stores of the omega-3 fatty acid are deposited in the brain. His team confirmed this finding, a discovery other labs have noted as well.
Aker BioMarine Antarctic announced the promotion of Matts Johansen to the position of chief operating officer. Johansen has served as executive vice president of marketing and sales since October 2009. During his tenure he has overseen sales growth in North America and Europe, and the development of the Asian markets in parallel with regulatory filings.
In this new role Johansen will be responsible for marketing and sales, business development, regulatory, research and development, shore-based production and process development.
Perth, Australia-based Algae.Tec, an advanced algae to biofuels company manufacturing enclosed algae growth and harvesting systems, has announced the commissioning for its showcase biofuels facility, Shoalhaven One, in Nowra, Australia. Algae.Tec Executive Chairman Roger Stroud said the commissioning process was on track for production of algae biomass in early June, ramping up to capacity by the end of June.
Growing International Interest In Oceanology To Benefit The Global Marine Biotechnology Market, According To New Report By Global Industry Analysts, Inc.Posted On: April 24, 2012
With growing environmental pollution throwing the spotlight on sustainable industrial development, there exists huge demand for suitable, scalable, economically, socially and environmentally sustainable feedstock options for the manufacturing industry. With sustainable feedstock production and delivery ballooning into a massive industry worldwide, the world’s oceans have emerged into the next frontier for investigative, biological resource development and management R&D projects.
For instance, marine-derived cosmetic ingredients, marine-derived molecules including enzymes, biopolymers and biomaterials, marine-derived pharmaceuticals, among others, are now becoming the mainstay of most R&D projects worldwide. The marine biotechnology sector is also attracting increased venture capital funds as is mirrored by the mushrooming of potential laden start-up firms focused on developing novel compounds from marine organisms.
As stated by the new market research report on Marine Biotechnology, Bioactive Substances represents one of the fastest growing market sectors trailing a projected CAGR of approximately 4.7% respectively.
The research report titled “Marine Biotechnology: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of the marine biotechnology markets, impact of recession on the markets, current market trends, key growth drivers, recent product introductions, recent industry activity, and profiles of major/niche global as well as regional market participants.
Sapphire Energy, a company that creates algae-based fuel, just announced a whopping $144 million in funding.
In recent years several startups have emerged to create fuel out of plant material, all hoping to lure people away from gasoline made from crude oil. Solazyme, Algae.tec, and Sapphire Energy all dominate the space, trying to edge out not only each other but oil companies as well.
All three companies covert algae into a petroleum replacement, one that can work with the traditional cars we already have on the road.
NUI Galway’s participation in Energetic Algae project (EnAlgae) investigates algae as sustainable energy sourcePosted On: March 23, 2012
Seaweed is big business in Asia, where it is cultivated and used in a variety of food and beauty products. Nine-tenths of the world’s production for commercial use takes place in China, Japan and Korea. It is also commonly used as a sugar-rich animal feedstock in the US.
Of the 500 species that can be found in Ireland, though, only a small number are harvested. Now researchers in at NUI Galway’s Ryan Institute are taking part in a European collaborative project to investigate the potential of algae as a source of sustainable energy.
Algal bio-energy development is still in its infancy, but NUI Galway’s participation in the Energetic Algae project (EnAlgae), a four-year, €1.2-million initiative which hopes to shed more light on this undervalued resource.
Oil produced from shrimp could soon be used as an ingredient in food supplement products in Europe.
But since the oil is a new and novel food ingredient with no significant history of consumption in the European Union before May 15, 1997, the product, to be known by the trade name Calanus® Oil, must go through the United Kingdom’s Advisory Committee on Novel Foods and Processes (ACNFP).
An arm of the Food Standards Agency, the ACNFP is taking public comments on the Calanus® oil application until March 1, 2012Comments are considered by the committee during its assessment of the novel food ingredient.
Calanus AS of Norway is the applicant. It plans to market the oil taken from the miniature shrimp Calanus finmarchicus, one of the most common zooplankton found in the North Atlantic Ocean.